Sara V R, Hall K, Rodeck C H, Wetterberg L
Proc Natl Acad Sci U S A. 1981 May;78(5):3175-9. doi: 10.1073/pnas.78.5.3175.
A radioreceptor assay utilizing human fetal brain plasma membrane as matrix and somatomedin A as ligand (fetal brain RRA-SMA) was developed. Increased levels of fetal brain RRA-SMA were found in the fetal circulation. The concentration was approximately 4-fold higher in the fetal as compared to the adult human. At birth, values fell within the adult range. In contrast, adult somatomedins determined by somatomedin radioimmunoassay were undetectable in the fetus and below the adult range at birth. Levels of fetal brain RRA-SMA were decreased in fetuses with different clinical disorders. In healthy newborns at cesarean section a significant correlation between serum fetal brain RRA-SMA values and birth weight and length was found. These results indicate the presence of an embryonic somatomedin in humans. The fetal brain RRA-SMA may provide a reliable index of fetal growth.
开发了一种以人胎儿脑膜为基质、生长调节素A为配体的放射受体分析法(胎儿脑RRA-SMA)。在胎儿循环中发现胎儿脑RRA-SMA水平升高。与成人相比,胎儿体内的浓度约高4倍。出生时,数值降至成人范围内。相比之下,通过生长调节素放射免疫分析法测定的成人生长调节素在胎儿体内无法检测到,且出生时低于成人范围。患有不同临床疾病的胎儿脑RRA-SMA水平降低。在剖宫产的健康新生儿中,发现血清胎儿脑RRA-SMA值与出生体重和身长之间存在显著相关性。这些结果表明人类存在一种胚胎生长调节素。胎儿脑RRA-SMA可能为胎儿生长提供可靠指标。